Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1998 Aug;53(8):685–691. doi: 10.1136/thx.53.8.685

Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis

M Gaga 1, A Bentley 1, M Humbert 1, J Barkans 1, F O'Brien 1, C Wathen 1, A Kay 1, S Durham 1
PMCID: PMC1745299  PMID: 9828857

Abstract

BACKGROUND—Bronchiectasis is a chronic suppurative lung disease characterised by irreversible dilation of the bronchi and persistent purulent sputum. The immunopathology of the disease was studied using a quantitative immunostaining technique with particular reference to T lymphocytes, macrophages, and granulocytes.
METHODS—Bronchial mucosal biopsy specimens were obtained by fibreoptic bronchoscopy from 12 patients with bronchiectasis (six receiving inhaled steroids) and 11 normal healthy controls. Immunostaining (APAAP method) was performed on frozen cryostat sections with a panel of monoclonal antibodies to total leucocytes (CD45), T lymphocyte phenotypic markers (CD3, CD4, CD8), macrophages (CD68), eosinophils (EG2), and neutrophils (elastase).
RESULTS—There was a mononuclear cell infiltrate in both patients with bronchiectasis and normal controls, but an overall increase in total leucocyte cell numbers (CD45+ cells) was identified in those with bronchiectasis (median values 422 cells/mm2 versus 113 cells/mm2 in control tissue, p<0.001). Intense infiltration of CD3+ T lymphocytes was observed compared with healthy controls (292 cells/mm2 and 40 cells/mm2, respectively, p<0.001). This comprised predominantly CD4+ T cells (118 cells/mm2) rather than CD8+ T cells (47 cells/mm2). CD3+ cell counts were reduced in those subjects on inhaled steroids compared with those not receiving inhaled steroids (197cells/mm2 versus 369 cells/mm2, p<0.05), as were CD4+ cell counts (82 cells/mm2 versus 190 cells/mm2, p<0.05). Neutrophil and macrophage cell numbers were also increased in patients with bronchiectasis (114 cells/mm2 and 213 cells/mm2, respectively) compared with controls (41 neutrophils/mm2 and 40 macrophages/mm2). EG2+ (activated) eosinophil numbers were much lower than T cells, macrophages, and neutrophils in patients with bronchiectasis but were increased compared with controls (36 cells/mm2 versus 0 cells/mm2, p<0.001). In view of the markedly increased neutrophil counts in patients with bronchiectasis, biopsy specimens were immunostained for interleukin 8 (IL-8) which was highly significantly increased compared with controls (47 cells/mm2 versus 15 cells/mm2, p<0.01). IL-8+ cells were less prominent in steroid treated patients than in patients not receiving treatment (30 cells/mm2 versus 60 cells/mm2, p<0.05). A further characteristic of bronchiectasis was mucous gland hypertrophy. Gland area comprised up to 40% of the tissue in some bronchiectasis sections while no hypertrophy was noted in control biopsy specimens (p<0.05).
CONCLUSION—Airway inflammation in bronchiectasis is characterised by tissue neutrophilia, a mononuclear cell infiltrate composed mainly of CD4+ T cells and CD68+ macrophages, and increased IL-8 expression. Inhaled corticosteroid treatment in patients with bronchiectasis is associated with a less marked infiltration by T cells and IL-8+ cells within the bronchial mucosa, although this finding requires confirmation in a prospective placebo controlled trial.



Full Text

The Full Text of this article is available as a PDF (178.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azzawi M., Bradley B., Jeffery P. K., Frew A. J., Wardlaw A. J., Knowles G., Assoufi B., Collins J. V., Durham S., Kay A. B. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1407–1413. doi: 10.1164/ajrccm/142.6_Pt_1.1407. [DOI] [PubMed] [Google Scholar]
  2. Barker A. F., Bardana E. J., Jr Bronchiectasis: update of an orphan disease. Am Rev Respir Dis. 1988 Apr;137(4):969–978. doi: 10.1164/ajrccm/137.4.969. [DOI] [PubMed] [Google Scholar]
  3. Bentley A. M., Hamid Q., Robinson D. S., Schotman E., Meng Q., Assoufi B., Kay A. B., Durham S. R. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med. 1996 Feb;153(2):551–556. doi: 10.1164/ajrccm.153.2.8564096. [DOI] [PubMed] [Google Scholar]
  4. Bentley A. M., Menz G., Storz C., Robinson D. S., Bradley B., Jeffery P. K., Durham S. R., Kay A. B. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis. 1992 Aug;146(2):500–506. doi: 10.1164/ajrccm/146.2.500. [DOI] [PubMed] [Google Scholar]
  5. Campbell D. A., du Bois R. M., Butcher R. G., Poulter L. W. The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis. Clin Exp Immunol. 1986 Jul;65(1):165–171. [PMC free article] [PubMed] [Google Scholar]
  6. Crystal R. G., Bitterman P. B., Rennard S. I., Hance A. J., Keogh B. A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med. 1984 Jan 26;310(4):235–244. doi: 10.1056/NEJM198401263100406. [DOI] [PubMed] [Google Scholar]
  7. Currie D. C., Pavia D., Agnew J. E., Lopez-Vidriero M. T., Diamond P. D., Cole P. J., Clarke S. W. Impaired tracheobronchial clearance in bronchiectasis. Thorax. 1987 Feb;42(2):126–130. doi: 10.1136/thx.42.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Elborn J. S., Johnston B., Allen F., Clarke J., McGarry J., Varghese G. Inhaled steroids in patients with bronchiectasis. Respir Med. 1992 Mar;86(2):121–124. doi: 10.1016/s0954-6111(06)80227-1. [DOI] [PubMed] [Google Scholar]
  9. Eller J., Lapa e Silva J. R., Poulter L. W., Lode H., Cole P. J. Cells and cytokines in chronic bronchial infection. Ann N Y Acad Sci. 1994 May 28;725:331–345. doi: 10.1111/j.1749-6632.1994.tb39816.x. [DOI] [PubMed] [Google Scholar]
  10. Fahy J. V., Schuster A., Ueki I., Boushey H. A., Nadel J. A. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases. Am Rev Respir Dis. 1992 Dec;146(6):1430–1433. doi: 10.1164/ajrccm/146.6.1430. [DOI] [PubMed] [Google Scholar]
  11. Frew A. J., Kay A. B. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol. 1988 Dec 15;141(12):4158–4164. [PubMed] [Google Scholar]
  12. Ip M., Lauder I. J., Wong W. Y., Lam W. K., So S. Y. Multivariate analysis of factors affecting pulmonary function in bronchiectasis. Respiration. 1993;60(1):45–50. doi: 10.1159/000196172. [DOI] [PubMed] [Google Scholar]
  13. Ip M., Shum D., Lauder I., Lam W. K., So S. Y. Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis. Respir Med. 1993 Aug;87(6):449–454. doi: 10.1016/0954-6111(93)90072-8. [DOI] [PubMed] [Google Scholar]
  14. Lapa e Silva J. R., Guerreiro D., Noble B., Poulter L. W., Cole P. J. Immunopathology of experimental bronchiectasis. Am J Respir Cell Mol Biol. 1989 Oct;1(4):297–304. doi: 10.1165/ajrcmb/1.4.297. [DOI] [PubMed] [Google Scholar]
  15. Mason D. Y., Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol. 1978 May;31(5):454–460. doi: 10.1136/jcp.31.5.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mukae H., Kadota J., Kohno S., Kusano S., Morikawa T., Matsukura S., Hara K. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med. 1995 Aug;152(2):613–618. doi: 10.1164/ajrccm.152.2.7633715. [DOI] [PubMed] [Google Scholar]
  17. Murphy M. B., Reen D. J., Fitzgerald M. X. Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax. 1984 Mar;39(3):179–184. doi: 10.1136/thx.39.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Owen C. A., Campbell E. J., Hill S. L., Stockley R. A. Increased adherence of monocytes to fibronectin in bronchiectasis. Regulatory effects of bacterial lipopolysaccharide and role of CD11/CD18 integrins. Am Rev Respir Dis. 1992 Mar;145(3):626–631. doi: 10.1164/ajrccm/145.3.626. [DOI] [PubMed] [Google Scholar]
  19. Poulter L. W., Duke O., Panayi G. S., Hobbs S., Raftery M. J., Janossy G. Activated T lymphocytes of the synovial membrane in rheumatoid arthritis and other arthropathies. Scand J Immunol. 1985 Dec;22(6):683–690. doi: 10.1111/j.1365-3083.1985.tb01931.x. [DOI] [PubMed] [Google Scholar]
  20. REID L. Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. Thorax. 1960 Jun;15:132–141. doi: 10.1136/thx.15.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rayner C. F., Rutman A., Dewar A., Cole P. J., Wilson R. Ciliary disorientation in patients with chronic upper respiratory tract inflammation. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):800–804. doi: 10.1164/ajrccm.151.3.7881674. [DOI] [PubMed] [Google Scholar]
  22. Saetta M., Di Stefano A., Maestrelli P., Ferraresso A., Drigo R., Potena A., Ciaccia A., Fabbri L. M. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis. 1993 Feb;147(2):301–306. doi: 10.1164/ajrccm/147.2.301. [DOI] [PubMed] [Google Scholar]
  23. Saetta M., Di Stefano A., Maestrelli P., Turato G., Ruggieri M. P., Roggeri A., Calcagni P., Mapp C. E., Ciaccia A., Fabbri L. M. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1646–1652. doi: 10.1164/ajrccm.150.6.7952628. [DOI] [PubMed] [Google Scholar]
  24. Silva J. R., Jones J. A., Cole P. J., Poulter L. W. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax. 1989 Aug;44(8):668–673. doi: 10.1136/thx.44.8.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tamaoki J., Chiyotani A., Kobayashi K., Sakai N., Kanemura T., Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis. 1992 Mar;145(3):548–552. doi: 10.1164/ajrccm/145.3.548. [DOI] [PubMed] [Google Scholar]
  26. WHITWELL F. A study of the pathology and pathogenesis of bronchiectasis. Thorax. 1952 Sep;7(3):213–239. doi: 10.1136/thx.7.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES